Previous studies have shown that tumor progression in metastatic colon cancer is associated with VEGF and EGFR (Epidermal Growth Factor Receptor) signaling, and that inhibitors targeting the VEGF family are used in colon cancer treatment [15]. Here, EGFR is linked to colonic neoplasm.